Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease
Peter R. Gibson, J. Robert E. Fraser, Tracey J. Brown, Caroline F. Finch, Penelope A. Jones, John C. Colman, Francis J. Dudley – 1 June 1992 – To define hepatic predictors of serum hyaluronan in patients with chronic liver disease, 62 patients with alcoholic liver disease were evaluated. In group 1, 30 patients had concurrent assessment of serum hyaluronan, liver function tests, Pugh grade and hemodynamic indices. A second, overlapping group of 42 patients (group 2) also had antipyrine clearance measured but without hemodynamic assessment.